Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Pediatr Dermatol ; 2024 Mar 26.
Article in English | MEDLINE | ID: mdl-38529733
2.
Pediatr Dermatol ; 41(3): 549-550, 2024.
Article in English | MEDLINE | ID: mdl-38299678

ABSTRACT

Infantile anogenital digitate keratoses (IADK) represent a distinct and under-recognized pediatric condition of the perianal area of infants, significantly more frequent in males than females. The average age of onset is 3.2 months, and it is self-remitting by 2 years of age. Perianal spiny keratoses resistant to usual topical therapies are the hallmark of IADK. We present a series of three cases of IADK seen at the dermatology clinic of the CHU Sainte-Justine to raise awareness on this pediatric condition, and to prevent invasive workup.


Subject(s)
Keratosis , Humans , Male , Infant , Female , Keratosis/pathology , Keratosis/drug therapy , Anus Diseases/pathology , Anus Diseases/drug therapy , Anal Canal/abnormalities , Anal Canal/pathology
5.
6.
JAMA Dermatol ; 159(8): 877, 2023 08 01.
Article in English | MEDLINE | ID: mdl-37342013

ABSTRACT

This case report describes an infant with frizzy, coarse, and fragile hair and low-set ears, blepharophimosis, and osteopenia.


Subject(s)
Hair Diseases , Trichothiodystrophy Syndromes , Humans , Trichothiodystrophy Syndromes/diagnosis , Trichothiodystrophy Syndromes/genetics , Hair , Sulfur , Hair Diseases/diagnosis
7.
CMAJ ; 195(12): E464-E465, 2023 03 27.
Article in French | MEDLINE | ID: mdl-36972907
9.
Pediatr Dermatol ; 40(4): 738-739, 2023.
Article in English | MEDLINE | ID: mdl-36825671

ABSTRACT

Segmental stiff skin syndrome is a rare fibrosing scleroderma-like disorder characterized by progressive indurations of the skin leading to joint contractures, decreased mobility, and pain. Treatment options are limited; we report a patient that showed improvement with anti-IL17 biologic therapy.


Subject(s)
Contracture , Skin Diseases, Genetic , Humans , Skin , Skin Diseases, Genetic/drug therapy , Contracture/drug therapy
10.
CMAJ ; 194(49): E1690, 2022 12 19.
Article in English | MEDLINE | ID: mdl-36535683
11.
J Cutan Med Surg ; 26(4): 349-360, 2022.
Article in English | MEDLINE | ID: mdl-35167768

ABSTRACT

BACKGROUND: Cutaneous hematologic malignancies are rare in children, and the literature about them is still sparse. OBJECTIVE: The purpose of our study was to report our experience with pediatric cases of cutaneous hematologic disorders and describe their clinical and histological features. METHODS: Data were retrospectively collected from the histopathologic database of the CHU Sainte-Justine, University of Montreal, Montreal, Canada. All patients up to 18 years of age with a diagnosis of a primary cutaneous lymphoma (including lymphomatoid papulosis), secondary cutaneous lymphoma or cutaneous manifestations of leukemia, followed from 1980 to 2019 at our center were reviewed. RESULTS: Thirty-six patients were included. Age at presentation ranged from birth to 18 years of age (mean 7.83 ± 5.16; median 7.0). Ten different hematologic disorders were identified according to the WHO-EORTC classifications: lymphomatoid papulosis (10 cases), mycosis fungoides (6 cases), anaplastic large cell lymphoma (4 cases), pre-B acute lymphoid leukemia (5 cases), primary cutaneous marginal zone B-cell lymphoma (4 cases), primary cutaneous CD4+medium T-cell lymphoproliferative disorder (1 case), extranodal NK/T-cell lymphoma (1 case), hydroa vacciniforme-like lymphoproliferative disorder (1 case), B-cell lymphoblastic lymphoma (1 case) and acute myeloid leukemia (3 cases). CONCLUSION: The most common subtype of cutaneous hematologic disease in our single institution study was lymphomatoid papulosis (type A and type C), followed by mycosis fungoides. Recognition of this large clinical and histological spectrum by dermatologists is important because diagnosis is often established by biopsy of skin lesions, even in secondary cutaneous cases. Moreover, the clinicopathological correlation is of utmost importance for the final diagnosis of those pathologies.


Subject(s)
Hematologic Diseases , Leukemia , Lymphoma, B-Cell , Lymphoma, T-Cell, Cutaneous , Lymphoma , Lymphomatoid Papulosis , Mycosis Fungoides , Skin Neoplasms , Adolescent , Child , Hematologic Diseases/complications , Humans , Leukemia/complications , Lymphoma/complications , Lymphoma/diagnosis , Lymphoma, B-Cell/complications , Lymphoma, T-Cell, Cutaneous/pathology , Lymphomatoid Papulosis/diagnosis , Mycosis Fungoides/diagnosis , Mycosis Fungoides/pathology , Retrospective Studies , Skin Neoplasms/pathology
13.
Pediatr Blood Cancer ; 68(12): e29364, 2021 12.
Article in English | MEDLINE | ID: mdl-34596969

ABSTRACT

Off-label drug prescribing, frequent in the treatment of vascular anomalies (VA), relies on the quality of the literature reporting drug efficacy and safety. Our objective is to review the level of evidence (LOE) surrounding drug use in VA, which is more prevalent in pediatric care. A list of drugs used in VA was created with a literature review in July 2020. For each drug listed, the article displaying the highest LOE was determined and then compared between efficacy/safety data, routes of administration, pharmacological categories and a subset of VA. The influence of research quality on study results was also explored. The median LOE for the 74 drugs identified poor methodological quality, with a predominance of retrospective studies or case reports. Drug safety is currently inadequately reported. This is alarming as many treatments display significant safety concerns. Also, current literature displays major publication bias that probably leads to overestimation of drug efficacy in VA.


Subject(s)
Sclerotherapy , Vascular Malformations , Child , Humans , Off-Label Use , Pharmaceutical Preparations , Retrospective Studies , Vascular Malformations/drug therapy
16.
Dermatology ; 237(4): 649-657, 2021.
Article in English | MEDLINE | ID: mdl-33823514

ABSTRACT

BACKGROUND: Off-label drug use is associated with an increased risk of adverse drug reactions. It is common in pediatrics and in rare diseases, which are two characteristics applying to vascular anomalies (VA). OBJECTIVES: The aim of this work was to quantify off-label drug use in VA and assess its safety. METHODS: A review was conducted to extract a list of drugs used in VA management. A drug was considered to have significant safety concerns if a black box warning was present or if a serious adverse drug reaction (SADR) was reported in at least 1% of the patients (SADR is defined as a noxious and unintended response to a drug that occurs at any dose and results in hospitalization, prolongation of existing hospitalization, congenital malformation, persistent or significant disability or incapacity, life-threatening condition, or death). The labelling status and safety of each drug was assessed based on the product monograph, Micromedex, and the FDA data. RESULTS: We found that 98.9% of the inventoried drugs were used off-label or unlicensed for VA management. Only the oral solution of propranolol hydrochloride (Hemangeol®) for the treatment of infantile hemangiomas is approved. Significant safety issues concerned 73% of the drugs and were more frequent among systemic than locally delivered drugs. CONCLUSIONS: Off-label drug use in VA is the rule and not the exception. Significant safety concerns are common. It is necessary to carefully weigh risk and benefits for every patient when using systemic and local treatments carrying safety concerns. Patients should be openly informed and involved in the decision-making process.


Subject(s)
Blood Vessels/abnormalities , Drug Labeling , Drug-Related Side Effects and Adverse Reactions , Off-Label Use , Congenital Abnormalities/drug therapy , Humans , Pharmaceutical Preparations
18.
Contact Dermatitis ; 2021 Feb 20.
Article in English | MEDLINE | ID: mdl-33609039
20.
SAGE Open Med Case Rep ; 8: 2050313X20935713, 2020.
Article in English | MEDLINE | ID: mdl-32676191

ABSTRACT

Deep granuloma annulare is an uncommon benign granulomatous skin disorder that presents almost exclusively in the paediatric population. It presents as an asymptomatic subcutaneous nodule with normal overlying skin on distal extremities, the scalp, or the forehead. It shows a deep palisading granuloma with areas of central necrobiosis on histologic examination. Due to its self-limited nature, clinical follow-up is recommended over surgical interventions. We present a case of cephalic deep granuloma annulare in a healthy 5-year-old girl who remains free of recurrence after surgical excision at the 6-month follow-up. Our case emphasizes the importance of differentiating the lesion from its clinical and histopathological mimickers, such as the rheumatoid nodule. The awareness of this entity is important to avoid the overinvestigation and overtreatment of a benign and self-limited disease.

SELECTION OF CITATIONS
SEARCH DETAIL
...